Claris Ventures’ Post

📢 We could not wish for a better start of 2024, with our portfolio company Resalis Therapeutics announcing a €10m financing round led by Sunstone Life Science Ventures, together with us and other previous investors including IAG and Club degli Investitori! Having led the very first financing in 2021, that allowed the company to conduct preclinical studies and be soon ready to move into clinical development, at Claris Ventures we are honored to have new experienced investors joining the syndicate - welcome Claus Andersson! ✌ Congratulations to Alessandro Toniolo, Sakari Kauppinen, Riccardo Panella and the whole team for the amazing work done so far, able to establish a unique positioning opportunity for our candidate RES-010 into the #obesity space, at the right moment. Onward and upward 🚀 For more information read the full announcement here: https://lnkd.in/dVCueQKr #biotech #vc #venturecapital #innovation #italy